Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention for Breast Cancer
Phase-Based Progress Estimates
Effectiveness
Safety
Mass General at North Shore Cancer Center, Danvers, MA
Breast Cancer+5 More
Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention - BehavioralEligibility
18+
Female
What conditions do you have?
Select
Eligibility
18+
Female
What conditions do you have?
Select
Study Summary
The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Eligible Conditions
- Breast Cancer
- Refusal, Treatment
- Survival Rate (Survivorship)
- Compliance, Treatment
- Treatment Adherence
Treatment Effectiveness
Effectiveness Progress
Other trials for Breast Cancer
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: Up to 3 months/12 weeks
Baseline (within 1-week of consent), 1-month, and 3-months post-baseline
Adjuvant endocrine therapy (AET) Initiation
Month 3
Program Acceptability
Program Feasibility
Trial Safety
Safety Progress
Other trials for Breast Cancer
Trial Design
1 Treatment Group
Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention · No Placebo Group · N/A
Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
Behavioral
Experimental Group · 1 Intervention: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 months/12 weeks
Closest Location: Mass General at North Shore Cancer Center · Danvers, MA
N/AFirst Recorded Clinical Trial
1 TrialsResearching Breast Cancer
0 CompletedClinical Trials
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,660 Previous Clinical Trials
30,828,767 Total Patients Enrolled
76 Trials studying Breast Cancer
125,481 Patients Enrolled for Breast Cancer
Jamie M Jacobs, PhDPrincipal InvestigatorMassachusetts General Hospital
Eligibility Criteria
Age 18+ · Female Participants · 7 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have an Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2.
You are a member of a racial or ethnic minority community.
You must be 21 years of age or older to participate in this study.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments